All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Mesoblast Limited revenue reports

Mesoblast Limited financial reports, Mesoblast Limited annual revenue in 2024. When does Mesoblast Limited report revenue?
Add to widgets
Added to widgets

Mesoblast Limited total revenue, net income and dynamics of changes in US dollar today

Mesoblast Limited current income and income for the latest reporting periods. Net revenue of Mesoblast Limited on 31/03/2021 amounted to 1 915 000 $. Net income of Mesoblast Limited today amounted to -26 515 000 $. Schedule of the financial report of Mesoblast Limited for today. Mesoblast Limited financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. The value of Mesoblast Limited assets on the online chart is displayed in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 1 915 000 $ +53.32 % ↑ -26 515 000 $ -
31/12/2020 2 241 000 $ +19.84 % ↑ -25 692 000 $ -
30/09/2020 1 305 000 $ -92.345 % ↓ -24 544 000 $ -
30/06/2020 701 000 $ -64.362 % ↓ -32 610 000 $ -
30/09/2019 17 048 000 $ - -5 484 000 $ -
30/06/2019 1 967 000 $ - -20 726 000 $ -
31/03/2019 1 249 000 $ - -24 970 000 $ -
31/12/2018 1 870 000 $ - -24 604 000 $ -
30/09/2018 11 637 000 $ - -19 498 000 $ -
30/06/2018 1 700 000 $ - -20 834 000 $ -
31/03/2018 1 070 000 $ - -21 137 000 $ -
31/12/2017 13 397 000 $ - 13 703 000 $ -
30/09/2017 1 174 000 $ - -7 022 000 $ -
30/06/2017 566 000 $ - -27 182 000 $ -
Show:
to

Mesoblast Limited financial report charts

Dates of Mesoblast Limited finance reports: 30/06/2017, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of Mesoblast Limited is 31/03/2021. Gross profit Mesoblast Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Mesoblast Limited is -5 417 000 $

Mesoblast Limited quarterly report dates

Cost of revenue Mesoblast Limited is the total cost of producing and distributing of products and services of a company. Cost of revenue Mesoblast Limited is 7 332 000 $ Total revenue Mesoblast Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Mesoblast Limited is 1 915 000 $ Operating income Mesoblast Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Mesoblast Limited is -25 906 000 $

Net income Mesoblast Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Mesoblast Limited is -26 515 000 $ Current assets Mesoblast Limited is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Mesoblast Limited is 169 766 000 $ Total assets Mesoblast Limited refers to the total amount of assets owned by a person or entity. Total assets Mesoblast Limited is 766 125 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-5 417 000 $ -4 209 000 $ -10 619 000 $ -9 152 000 $ 14 350 000 $ -481 000 $ -1 944 000 $ -3 531 000 $ 7 320 000 $ -421 000 $ -639 000 $ - - -
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
7 332 000 $ 6 450 000 $ 11 924 000 $ 9 853 000 $ 2 698 000 $ 2 448 000 $ 3 193 000 $ 5 401 000 $ 4 317 000 $ 2 121 000 $ 1 709 000 $ - - -
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
1 915 000 $ 2 241 000 $ 1 305 000 $ 701 000 $ 17 048 000 $ 1 967 000 $ 1 249 000 $ 1 870 000 $ 11 637 000 $ 1 700 000 $ 1 070 000 $ 13 397 000 $ 1 174 000 $ 566 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 17 048 000 $ 1 967 000 $ 1 249 000 $ 1 870 000 $ 11 637 000 $ 1 700 000 $ 1 070 000 $ 13 397 000 $ 1 174 000 $ 941 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-25 906 000 $ -26 314 000 $ -35 641 000 $ -32 807 000 $ -3 903 000 $ -17 543 000 $ -21 681 000 $ -24 949 000 $ -16 783 000 $ -22 801 000 $ -23 607 000 $ -9 269 000 $ -20 083 000 $ -24 863 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-26 515 000 $ -25 692 000 $ -24 544 000 $ -32 610 000 $ -5 484 000 $ -20 726 000 $ -24 970 000 $ -24 604 000 $ -19 498 000 $ -20 834 000 $ -21 137 000 $ 13 703 000 $ -7 022 000 $ -27 182 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
12 441 000 $ 14 238 000 $ 19 278 000 $ 15 266 000 $ 12 389 000 $ 11 435 000 $ 14 407 000 $ 15 488 000 $ 18 489 000 $ 17 539 000 $ 16 798 000 $ 16 222 000 $ 15 368 000 $ 15 939 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
27 821 000 $ 28 555 000 $ 36 946 000 $ 33 508 000 $ 20 951 000 $ 19 510 000 $ 22 930 000 $ 26 819 000 $ 28 420 000 $ 24 501 000 $ 24 677 000 $ 22 666 000 $ 21 257 000 $ 36 344 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
169 766 000 $ 90 458 000 $ 115 737 000 $ 136 548 000 $ 60 593 000 $ 62 522 000 $ 85 527 000 $ 97 801 000 $ 97 811 000 $ 101 071 000 $ 86 069 000 $ 72 272 000 $ 80 327 000 $ 63 609 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
766 125 000 $ 687 310 000 $ 712 572 000 $ 733 602 000 $ 653 786 000 $ 652 115 000 $ 675 705 000 $ 688 333 000 $ 688 789 000 $ 692 443 000 $ 677 859 000 $ 664 811 000 $ 671 898 000 $ 655 686 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
158 263 000 $ 77 528 000 $ 108 123 000 $ 129 328 000 $ 34 536 000 $ 50 426 000 $ 70 385 000 $ 77 022 000 $ 55 143 000 $ 37 763 000 $ 59 539 000 $ 47 386 000 $ 62 941 000 $ 45 761 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 70 092 000 $ 44 331 000 $ 44 502 000 $ 33 809 000 $ 27 393 000 $ 24 003 000 $ 24 861 000 $ - - -
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - - - - - 47 386 000 $ 62 941 000 $ 45 761 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 178 639 000 $ 171 063 000 $ 174 763 000 $ 163 776 000 $ 161 190 000 $ 146 435 000 $ 121 724 000 $ - - -
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 27.32 % 26.23 % 25.86 % 23.79 % 23.40 % 21.15 % 17.96 % - - -
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
600 930 000 $ 518 731 000 $ 538 506 000 $ 549 326 000 $ 475 147 000 $ 481 052 000 $ 500 942 000 $ 524 557 000 $ 527 599 000 $ 546 008 000 $ 556 135 000 $ 575 605 000 $ 559 590 000 $ 516 766 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -15 558 000 $ -19 086 000 $ -21 189 000 $ 2 029 000 $ -19 544 000 $ -20 188 000 $ -19 603 000 $ -14 865 000 $ -20 356 000 $ -23 435 000 $

Last revenue report of Mesoblast Limited was 31/03/2021. According to last financial report total revenue in Mesoblast Limited was 1 915 000 US dollar and changed by +53.32% since last year. Net income in Mesoblast Limited was -26 515 000 $ in last quartal, net income changes to 0%.

Current cash Mesoblast Limited - the sum of all of the cash a company has on the date of report. Current cash Mesoblast Limited is 158 263 000 $

Mesoblast Limited stocks data

Mesoblast Limited financials